#TheRightDose
Medical Community, MBC Patients, Patient Advocates, Diagnosis and Treatment, Long Term Adverse Effects, Obstacles to Better Outcomes, Patient Reported Outcomes and Out of the Box Treatment Options, Living with MBC, Essential Knowledge Our MBClife Medical Community, MBC Patients, Patient Advocates, Diagnosis and Treatment, Long Term Adverse Effects, Obstacles to Better Outcomes, Patient Reported Outcomes and Out of the Box Treatment Options, Living with MBC, Essential Knowledge Our MBClife

#TheRightDose

Anne Loeser and Dr. Aditya Bardia join the podcast to talk about the importance of getting The Right Dose.

Read More
All About Lobular Breast Cancer
MBC Allies, Medical Community, Entities of Cancer, Essential Knowledge, Difficult to Treat, Obstacles to Better Outcomes, Diagnosis and Treatment, MBC Imaging and Profiling, Clinical Research, Translational Research, Novel Treatments Our MBClife MBC Allies, Medical Community, Entities of Cancer, Essential Knowledge, Difficult to Treat, Obstacles to Better Outcomes, Diagnosis and Treatment, MBC Imaging and Profiling, Clinical Research, Translational Research, Novel Treatments Our MBClife

All About Lobular Breast Cancer

Did you know that not ALL breast cancer can be detected by a lump? We are joined by Laurie Hutcheson of the Lobular Breast Cancer Alliance and researchers Steffi Oesterreich, PhD and Adrian Lee, PhD why ILC is difficult to research and what looks promising for the future.

Read More
Nancy U. Lin, MD
Medical Community, Novel Treatments, Essential Knowledge, Diagnosis and Treatment, Challenges and Barriers, Obstacles to Better Outcomes, Clinical Research, Difficult to Treat, MBC Imaging and Profiling, Entities of Cancer Our MBClife Medical Community, Novel Treatments, Essential Knowledge, Diagnosis and Treatment, Challenges and Barriers, Obstacles to Better Outcomes, Clinical Research, Difficult to Treat, MBC Imaging and Profiling, Entities of Cancer Our MBClife

Nancy U. Lin, MD

A conversation with Dr. Nancy Lin, Director of the Metastatic Breast Cancer Program at Dana-Farber Cancer Institute.

Read More